Eisai Ltd ADR (OP:ESALY)

N/A UNCHANGED

Last Price Updated: 3:59 PM EST, Jan 30, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eisai Ltd ADR

< Previous 1 2 3 4 5 6 7 Next >

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Bristol Myers Inks Licensing Pact For Eisai's Folate Receptor ADC Drug, Lays Out Over $3B For Rights ↗

June 18, 2021

Eisai Co Ltd (OTC: ESALY) and Bristol-Myers Squibb Co (NYSE: BMY) have entered into an exclusive global strategic collaboration agreement for the co-...

Via Benzinga

Two Rate Hikes In 2023 ↗

June 16, 2021

This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard.

Via Talk Markets

Topics Economy

Continued Uncertainty ↗

June 15, 2021

Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.

Via Talk Markets

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

Happy Friday ↗

June 11, 2021

The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer.

Via Talk Markets

Unheeding Markets ↗

June 10, 2021

Today oil prices rose over $70.

Via Talk Markets

Wednesday News And Catch-Up ↗

June 09, 2021

Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.

Via Talk Markets

Topics Stocks

FDA surprise ↗

June 07, 2021

The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year.

Via Talk Markets

Biogen's Alzheimer's Disease Treatment Earns FDA Approval ↗

June 07, 2021

Aducanumab becomes the first available treatment intended to stop patients with Alzheimer's disease from losing more memories.

Via The Motley Fool

Why Biogen Stock Is On Fire Today ↗

June 07, 2021

The biotech's controversial Alzheimer's disease drug got a green light from the FDA.

Via The Motley Fool

Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib ↗

June 07, 2021

Merck & Co Inc (NYSE: MRK) has announced new data from Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial, which evaluated the combinations of Keytruda (pembrolizumab...

Via Benzinga

A Better Switch ↗

June 04, 2021

Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.

Via Talk Markets

Ahead Of Judgement Day, FDA Faces Test with Biogen's Alzheimer's Drug Decision ↗

June 04, 2021

U.S. regulators are slated to decide by Monday whether to approve Biogen Inc’s (NASDAQ: BIIB) much-talked-about Alzheimer’s disease drug, aducanumab....

Via Benzinga

Fan Hit ↗

June 03, 2021

The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.

Via Talk Markets

Wonder Products ↗

June 02, 2021

Meme is alive and well.

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ↗

June 01, 2021

The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...

Via Benzinga

More Inflationary Pressures ↗

May 28, 2021

Today, we saw more evidence of worrying inflationary pressures from the personal consumption index hitting 3.1% in April over prior April, up sharply from the March rise of 1.9%.

Via Talk Markets

New New Deal Worries ↗

May 27, 2021

Nio is up 1.4% today on another round of Meme buying.

Via Talk Markets

Good Times For Gold ↗

May 26, 2021

Gold is rising some more, in part as an alternative to crypto.

Via Talk Markets

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

Better Mood Day ↗

May 20, 2021

The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.

Via Talk Markets

Why Biogen's June 7 Aducanumab PDUFA Date Is A High-Risk, High-Reward Catalyst ↗

May 19, 2021

As the day of reckoning for Biogen Inc.'s (NASDAQ: BIIB) controversial Alzheimer's product candidate aducanumab draws close, an analyst at Oppenheimer looked at the...

Via Benzinga

A Down Day ↗

May 12, 2021

The tech wreck continues because inflation will hurt the costly stock sector more than others.

Via Talk Markets

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

Inflation Shock ↗

May 06, 2021

Markets are up because jobs data were much better than expected, below 500,000 for the first week since Covid-19 started last week.

Via Talk Markets

Tuesday Market Report ↗

April 27, 2021

Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.

Via Talk Markets

Robots ↗

April 19, 2021

Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs.

Via Talk Markets

Electric Cancer Cure ↗

April 13, 2021

Most US stocks were down on fear of inflation and financial risks but then rose after lunch.

Via Talk Markets

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.